|
34.
|
|
3 p, 226.3 KB |
Intrarenal venous flow in cardiorenal syndrome : a shining light into the darkness
/
De la Espriella, Rafael (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Núñez, Eduardo (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Miñana, Gema (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Sanchis, Juan (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ;
González, Jessika (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Chorro, Javier (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Núñez, Julio (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares)
The aim of this case report is to assess the potential role of intrarenal Doppler ultrasonography as a non-invasive method to evaluate intrarenal venous flow (IRVF) in acute heart failure (AHF) and concomitant renal dysfunction. [...]
2018 -  10.1002/ehf2.12362
ESC Heart Failure, Vol. 5 (october 2018) , p. 1173-1175
|
|
|
35.
|
|
11 p, 2.0 MB |
Long-term LVEF trajectories in patients with type 2 diabetes and heart failure : diabetic cardiomyopathy may underlie functional decline
/
Julián, María Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Alonso Pedrol, Núria (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gavidia-Bovadilla, Giovana (Hospital Clínic Universitari (València)) ;
Ferrer, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
de Antonio Ferrer, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
López-Ayerbe, Jorge (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Domingo, Mar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santiago Vacas, Evelyn (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Zamora, Elisabet (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Codina, Pau (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Moliner, Pedro (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Núñez, Julio (Universitat de València. Departament de Medicina) ;
Santesmases, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Puig Domingo, Manuel (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Left ventricular ejection fraction (LVEF) trajectories and functional recovery with current heart failure (HF) management is increasingly recognized. Type 2 diabetes mellitus (T2D) leads to a worse prognosis in HF patients. [...]
2020 - 10.1186/s12933-020-01011-w
Cardiovascular diabetology, Vol. 19 (march 2020)
|
|
|
36.
|
|
8 p, 326.6 KB |
Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction
/
Santas, Enrique (Hospital Clínic Universitari (València)) ;
De la Espriella, Rafael (Hospital Clínic Universitari (València)) ;
Palau, Patricia (Consorci Hospitalari Provincial de Castelló) ;
Miñana, Gema (Hospital Clínic Universitari (València)) ;
Amiguet, Martina (Hospital Clínic Universitari (València)) ;
Sanchis, Juan (Hospital Clínic Universitari (València)) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Chorro, Francisco J. (Hospital Clínic Universitari (València)) ;
Núñez Villota, Julio (Hospital Clínic Universitari (València)) ;
Universitat Autònoma de Barcelona
Heart failure with mid-range ejection fraction (HFmrEF) has been proposed as a distinct HF phenotype, but whether patients on this category fare worse, similarly, or better than those with HF with reduced EF (HFrEF) or preserved EF (HFpEF) in terms of rehospitalization risks over time remains unclear. [...]
2020 - 10.1002/ehf2.12683
ESC Heart Failure, Vol. 7 (march 2020) , p. 1007-1014
|
|
|
37.
|
|
17 p, 1.2 MB |
Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron : The Myocardial- Trial
/
Núñez, Julio (Universitat Jaume I) ;
Miñana, Gema (Universitat Jaume I) ;
Cardells, Ingrid (Hospital Clínic Universitari (València)) ;
Palau, Patricia (Universitat Jaume I. Hospital General de Castellón) ;
Llàcer, Pau (Hospital de Manises (València)) ;
Fácila, Lorenzo (Hospital General Universitario de Valencia) ;
Almenar Bonet, Luis (Hospital Universitari i Politècnic La Fe (València)) ;
López-Lereu, Maria P. (Hospital Clínic Universitari (València)) ;
Monmeneu, Jose V. (Hospital Clínic Universitari (València)) ;
Amiguet, Martina (Hospital Clínic Universitari (València)) ;
González, Jessika (Hospital Clínic Universitari (València)) ;
Serrano, Alicia (Consorci Hospitalari Provincial de Castelló) ;
Montagud, Vicente (Hospital General Universitario de Valencia) ;
López-Vilella, Raquel (Hospital Universitari i Politècnic La Fe (València)) ;
Valero, Ernesto (Universitat Jaume I) ;
García-Blas, Sergio (Universitat Jaume I) ;
Bodi, Vicente (Universitat Jaume I) ;
De la Espriella, Rafael (Hospital Clínic Universitari (València)) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Navarro, Jorge (Universitat de València) ;
Górriz, José Luis (Universitat de València) ;
Sanchis, Juan (Universitat Jaume I) ;
Chorro, Francisco J. (Universitat Jaume I) ;
Comín-Colet, Josep (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Intravenous ferric carboxymaltose () improves symptoms, functional capacity, and quality of life in heart failure and iron deficiency. The mechanisms underlying these effects are not fully understood. [...]
2020 - 10.1161/JAHA.119.014254
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 9 (february 2020)
|
|
|
38.
|
|
8 p, 940.6 KB |
Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure : a pilot study
/
Revuelta-López, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Núñez, Julio (Hospital Clínic Universitari (València)) ;
Gastelurrutia, Paloma (Institut Germans Trias i Pujol) ;
Januzzi, James L. (Massachusetts General Hospital and Cardiometabolic Trials, Baim Institute for Clinical Research) ;
Ibrahim, Nasrien E. (Massachusetts General Hospital and Cardiometabolic Trials, Baim Institute for Clinical Research) ;
Emdin, Michele (Scuola Superiore Sant'Anna, Fondazione Toscana Gabriele Monasterio) ;
VanKimmenade, Roland (Radboud University Medical Centre) ;
Pascual-Figal, Domingo (Universidad de Murcia) ;
Núñez, Eduardo (Hospital Clínic Universitari (València)) ;
Gommans, Frank (Radboud University Medical Centre) ;
Lupón, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina)
Sacubitril/valsartan is a first-in-class angiotensin receptor-neprilysin inhibitor developed for the treatment of heart failure with reduced ejection fraction. Its benefits are achieved through the inhibition of neprilysin (NEP) and the specific blockade of the angiotensin receptor AT1. [...]
2020 - 10.1002/ehf2.12607
ESC Heart Failure, Vol. 7 (february 2020) , p. 559-566
|
|
|
39.
|
|
11 p, 407.0 KB |
Sodium-glucose cotransporter 2 inhibition : towards an indication to treat diabetic kidney disease
/
Górriz, Jose Luis (Red de Investigación Renal) ;
Navarro-González, Juan F. (Universidad de La Laguna. Instituto de Tecnologías Biomédicas) ;
Ortiz, Alberto (IIS-Fundación Jimenez Diaz UAM and School of Medicine) ;
Vergara, Ander (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Núñez, Julio (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Jacobs-Cachá, Conxita (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martínez-Castelao, Alberto (Hospital Universitari de Bellvitge) ;
Soler, María José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have clearly demonstrated their beneficial effect in diabetic kidney disease (DKD) on top of the standard of care [blood glucose control, renin-angiotensin system blockade, smoking cessation and blood pressure (BP) control], even in patients with overt DKD. [...]
2020 - 10.1093/ndt/gfz237
Nephrology Dialysis Transplantation, Vol. 35 (January 2020) , p. i13-i23
|
|
|
40.
|
|
10 p, 1.1 MB |
Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes
/
Iborra Egea, Oriol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santiago Vacas, Evelyn (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Yurista, Salva R. (Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Packer, Milton (Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas) ;
Heymans, Stephane (Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands) ;
Zannad, Faiez (Université de Lorraine. Centre d'Investigation Clinique Plurithématique) ;
Butler, Javed (Department of Medicine, University of Mississippi, Jackson, Mississippi) ;
Pascual-Figal, Domingo (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Lax, Antonio (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Núñez, Julio (Hospital Clínic Universitari (València)) ;
de Boer, Rudolf A.. (Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
The mechanism of action of empagliflozin in heart failure with reduced ejection fraction (HFrEF) was deciphered using deep learning in silico analyses together with in vivo validation. The most robust mechanism of action involved the sodium-hydrogen exchanger (NHE)-1 co-transporter with 94. [...]
2019 - 10.1016/j.jacbts.2019.07.010
JACC: Basic to Translational Science, Vol. 4 Num. 7 (November 2019) , p. 831-840
|
|
|
41.
|
|
10 p, 1.9 MB |
Magnetic resonance microscopy and correlative histopathology of the infarcted heart
/
Perez-Terol, Itziar (Instituto de Investigación Sanitaria INCLIVA (València, Comunitat Valenciana)) ;
Rios-Navarro, César (Hospital Clínic Universitari (València)) ;
de Dios, Elena (Hospital Clínic Universitari (València)) ;
Morales, José Manuel (Pathology Department. School of Medicine. University of Valencia) ;
Gavara Doñate, Jose (Hospital Clínic Universitari (València)) ;
Perez-Sole, Nerea (Hospital Clínic Universitari (València)) ;
Diaz, Ana (Unidad Central de Investigación Biomédica. University of Valencia) ;
Minana, Gema (Medicine Department. School of Medicine. University of Valencia) ;
Segura-Sabater, Remedios (Instituto de Investigación Sanitaria INCLIVA (València, Comunitat Valenciana)) ;
Bonanad, Clara (Medicine Department. School of Medicine. University of Valencia) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Husser, Oliver (St. Johannes Hospital(Alemania)) ;
Monmeneu, José V. (Cardiovascular Magnetic Resonance Unit. ERESA) ;
Lopez-Lereu, María P. (Cardiovascular Magnetic Resonance Unit. ERESA) ;
Núñez, Julio (Medicine Department. School of Medicine. University of Valencia) ;
Chorro, Francisco J. (Medicine Department. School of Medicine. University of Valencia) ;
Ruiz-Sauri, Amparo (Pathology Department. School of Medicine. University of Valencia) ;
Bodi, Vicente (Medicine Department. School of Medicine. University of Valencia) ;
Monleon, Daniel (Centro de Investigación Biomédica en Red sobre Fragilidad y Envejecimiento Saludable) ;
Universitat Autònoma de Barcelona
Delayed enhancement cardiovascular magnetic resonance (MR) is the gold-standard for non-invasive assessment after myocardial infarction (MI). MR microscopy (MRM) provides a level of detail comparable to the macro objective of light microscopy. [...]
2019 - 10.1038/s41598-019-56436-5
Scientific reports, Vol. 9 Núm. 1 (january 2019) , p. 20017
|
|
|
42.
|
|
10 p, 559.2 KB |
Genetic etiology for alcohol-induced cardiac toxicity
/
Ware, James S. (Imperial College London. National Heart and Lung Institute) ;
Amor-Salamanca, Almudena (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Tayal, Upasana (Imperial College London. National Heart and Lung Institute) ;
Govind, Risha (Imperial College London. National Heart and Lung Institute) ;
Serrano, Isabel (Hospital Universitari Joan XXIII de Tarragona) ;
Salazar-Mendiguchía, Joel (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
García-Pinilla, José Manuel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Pascual-Figal, Domingo A. (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Núñez, Julio (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Guzzo-Merello, Gonzalo (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
González-Vioque, Emiliano (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Bardají, Alfredo (Hospital Universitari Joan XXIII de Tarragona) ;
Manito, Nicolas (Hospital Universitari de Bellvitge) ;
López-Garrido, Miguel A. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Padron-Barthe, Laura (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Edwards, Elizabeth (Imperial College London. National Heart and Lung Institute) ;
Whiffin, Nicola (Imperial College London. National Heart and Lung Institute) ;
Walsh, Roddy (Imperial College London. National Heart and Lung Institute) ;
Buchan, Rachel J. (Imperial College London. National Heart and Lung Institute) ;
Midwinter, William (Imperial College London. National Heart and Lung Institute) ;
Wilk, Alicja (Imperial College London. National Heart and Lung Institute) ;
Prasad, Sanjay (Imperial College London. National Heart and Lung Institute) ;
Pantazis, Antonis (Royal Brompton and Harefield. Cardiovascular Research Centre) ;
Baski, John (Royal Brompton and Harefield. Cardiovascular Research Centre) ;
O'Regan, Declan P. (Imperial College London. MRC London Institute of Medical Sciences) ;
Alonso-Pulpón, Luis (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Cook, Stuart A. (Imperial College London. National Heart and Lung Institute) ;
Lara-Pezzi, Enrique (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Barton, Paul J. (Imperial College London. National Heart and Lung Institute) ;
García-Pavía, Pablo (Universidad Francisco de Vitoria)
Alcoholic cardiomyopathy (ACM) is defined by a dilated and impaired left ventricle due to chronic excess alcohol consumption. It is largely unknown which factors determine cardiac toxicity on exposure to alcohol. [...]
2018 - 10.1016/j.jacc.2018.03.462
Journal of the American College of Cardiology, Vol. 71, issue 20 (May 2018) , p. 2293-2302
|
|
|
43.
|
|
9 p, 933.2 KB |
Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction
/
Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rueda, Ferran (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Oxvig, Claus (Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark) ;
Oliveras, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Labata, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
De Diego, Oriol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ferrer Massot, Marc (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Aranda-Nevado, M. Cruz (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Serra-Gregori, Judith (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Núñez, Julio (Universitat de València. Departament de Medicina) ;
García, Cosme (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
The aim of the present study was to evaluate the prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in patients with ST-segment elevation myocardial infarction (STEMI). Observational cohort study performed in 1085 consecutive STEMI patients treated with early reperfusion between February 2011 and August 2014. [...]
2018 - 10.1186/s12933-018-0710-3
Cardiovascular diabetology, Vol. 17 (april 2018)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
